Table 5.
Multivariable analysis of predictors of major bleeding
| Variable | Hazard ratio (95% confidence interval) | P-value |
|---|---|---|
| Age | 1.03 (1.00 – 1.06) | 0.03 |
| Female | 0.87 (0.60 – 1.27) | 0.47 |
| Body mass index | 1.02 (0.99 – 1.05) | 0.19 |
| Apixaban (reference) | ||
| Dabigatran | 0.88 (0.53 – 1.45) | 0.61 |
| Rivaroxaban | 1.51 (1.02 – 2.22) | 0.04 |
| Off-label low dose of DOAC | 1.03 (0.62 – 1.73) | 0.90 |
| CHA2DS2-VASc score | 1.20 (1.06 – 1.36) | 0.004 |
| Interacting medication | 0.53 (0.34 – 0.83) | 0.006 |
| Serum sodium | 0.97 (0.92 – 1.01) | 0.1538 |
| Creatinine clearance | 0.99 (0.99 – 1.00) | 0.1904 |